These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1827499)

  • 1. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
    Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
    J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis.
    Perlmutter JS; Kilbourn MR; Welch MJ; Raichle ME
    J Neurosci; 1989 Jul; 9(7):2344-52. PubMed ID: 2787394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
    Moerlein SM; Perlmutter JS; Markham J; Welch MJ
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
    Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
    Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).
    Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND
    Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.
    Wang GJ; Volkow ND; Fowler JS; Wolf AP; MacGregor RR; Shea CE; Schlyer DJ; Hitzemann RJ
    Synapse; 1993 Nov; 15(3):246-9. PubMed ID: 8278901
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic and benzodiazepine receptors studied in vivo by PET.
    Hantraye P; Mazière B; Mazière M; Fukuda H; Naquet R
    J Physiol (Paris); 1986; 81(4):278-82. PubMed ID: 3033225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.